ConductScience.org, home

Paper16306358

Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.

Rahmoune H and 5 others. Diabetes, 2005. Cited by 623 papers, by iCite.

Cite this record

ConductScience Library. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Papers, record 16306358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16306358

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.
PubMed
Journal
Diabetes
PubMed
Year
2005
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
623
iCite
Relative citation ratio, by iCite
14.4
iCite
Revised in PubMed
2022-04-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rahmoune HHassan
2Thompson PWPaul W
3Ward JMJoanna M
4Smith CDChari D
5Hong GGuizhu
6Brown JJohn

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Glucose Transport Proteins, FacilitativeMajor topic
Kidney Tubules, ProximalMajor topic
UrineMajor topic
Base Sequence
Biological Transport
DNA Primers
Epithelial Cells
Glucose
Humans
Microscopy, Confocal
Polymerase Chain Reaction

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02798744SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation.BackgroundClinicalTrials.gov
NCT02887677Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes.BackgroundClinicalTrials.gov
NCT05727423Dapagliflozin in the Treatment of Heart FailureBackgroundClinicalTrials.gov

Download CSV of trials

Cited by319

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 623 citations.

PMIDTitleJournalYearIn PapersSource
42927000A Cost-Effective, Kit-Free Method for Extracting Nuclear and Mitochondrial DNA From Low-Abundance Cells in Urine Samples.Cureus2026https://conductscience.org/library/papers/42927000PubMed
42418090Renal glucose metabolic enzyme expression during AKI-to-CKD transition.Int Urol Nephrol2026https://conductscience.org/library/papers/42418090PubMed
42009842Salt and chronic kidney disease.Nat Rev Nephrol2026https://conductscience.org/library/papers/42009842PubMed
41930239Treatment of Youth-Onset Type 2 Diabetes: Focus on SGLT-2 Inhibitor Use.Pediatr Diabetes2026https://conductscience.org/library/papers/41930239PubMed
41550024Imbalance of mitochondria and abnormalities in lipid metabolism in Diabetic Tubulopathy.Ann Med2026https://conductscience.org/library/papers/41550024PubMed
41323303"Sweating Kidneys" refers to perirenal effusion as a complication of SGLT2i: A case reports.Urol Case Rep2026https://conductscience.org/library/papers/41323303PubMed
41301689Complementary Yet Distinct Roles of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction.Biomedicines2025https://conductscience.org/library/papers/41301689PubMed
41163811Estimated Glomerular Filtration Rate and Incident Prediabetes Risk in Normoglycemic Adults With Parental Type 2 Diabetes.J Endocr Soc2025https://conductscience.org/library/papers/41163811PubMed
41009421Thyroid Hormones Regulate Postprandial Glucose Metabolism by Regulating SGLT1 Expression in the Small Intestine in Rats and Mice.Int J Mol Sci2025https://conductscience.org/library/papers/41009421PubMed
40943149Diabetic Kidney Disease: From Pathophysiology to Regression of Albuminuria and Kidney Damage: Is It Possible?Int J Mol Sci2025https://conductscience.org/library/papers/40943149PubMed
40928723A review of the effect of SGLT2 inhibitors on clinical and glycemic outcomes in hospitalized patients: data from studies that included patients with diabetes.Hormones (Athens)2026https://conductscience.org/library/papers/40928723PubMed
40926738An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in the renal capillaries and protects the capillary network in the diabetic rats.Diabetes Obes Metab2025https://conductscience.org/library/papers/40926738PubMed
40564143Pathogenesis and Therapeutic Perspectives of Tubular Injury in Diabetic Kidney Disease: An Update.Biomedicines2025https://conductscience.org/library/papers/40564143PubMed
40540353Noninvasive Assessment of Urinary Exfoliated Proximal Tubule Cell Multispectral Autofluorescence May Differentiate between Causes of Kidney Transplant Dysfunction.Kidney3602025https://conductscience.org/library/papers/40540353PubMed
40445480D-Glucose and its derivatives labeled with radioactive carbon and hydrogen: key tools for investigating biological processes and molecular mechanisms.EJNMMI Radiopharm Chem2025https://conductscience.org/library/papers/40445480PubMed
40411658The Role of Diabetes and SGLT2 Inhibitors in Cerebrovascular Diseases.Curr Neurol Neurosci Rep2025https://conductscience.org/library/papers/40411658PubMed
40349958Epigallocatechin gallate prevents and alleviates type 2 diabetes mellitus (T2DM) through gut microbiota and multi-organ interactions in Wistar healthy rats and GK T2DM rats.J Adv Res2026https://conductscience.org/library/papers/40349958PubMed
40302966Efficacy and Safety of SGLT2 Inhibitors in Pediatric Patients and Young Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Pediatr Diabetes2024https://conductscience.org/library/papers/40302966PubMed
40208690Coordinated Regulation of Renal Glucose Reabsorption and Gluconeogenesis by mTORC2 and Potassium.J Am Soc Nephrol2025https://conductscience.org/library/papers/40208690PubMed
40164842[Effects of "new" antidiabetic drugs on management of anesthesia].Anaesthesiologie2025https://conductscience.org/library/papers/40164842PubMed

See all 319 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANPEP290PubTator's text mininghttps://conductscience.org/library/genes/290NCBI Gene
SLC2A26514PubTator's text mininghttps://conductscience.org/library/genes/6514NCBI Gene
SLC5A26524PubTator's text mininghttps://conductscience.org/library/genes/6524NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16306358

GET https://conductscience.org/api/papers/v1/16306358/cited_by?page=2